BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

Syensqo and Emulseo Partner to Advance Microfluidic Innovations in Healthcare

Syensqo, a leading specialty chemicals company, is pleased to announce a strategic partnership with Emulseo, a French company specialized in formulations f...

February 21, 2025 | News

PranaQ Secures FDA Clearance for TipTraQ, an AI-Powered Home Sleep Apnea Testv

PranaQ, backed by NAVER D2SF continues to push the boundaries of AI-powered healthcare solutions. NAVER D2SF, NAVER's corporate venturing arm, actively col...

February 21, 2025 | News

Australia Grants First Global Market Approval for YORVIPATH® to Treat Chronic Hypoparathyroidism

YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism...

February 21, 2025 | News

BioMed X Launches Research Hub in Barbados to Advance Cardiometabolic Disease Treatment for Individuals of African Descent

BioMed X Institute, in collaboration with the Government of Barbados and the European Commission, is launching BioMed X Barbados, a new rese...

February 21, 2025 | News

Adalvo and Wyntra Launch First Women’s Health Treatment in the UK, Expanding Access for Endometriosis Care

Adalvo, in collaboration with Wyntra announce a significant milestone with the first launch from Adalvo’s Women's Health portfolio in the UK, re...

February 20, 2025 | News

NERLYNX® Approved in Thailand for Early and Advanced HER2+ Breast Cancer Treatment

NERLYNX® (neratinib) has been approved as a single agent for the treatment of early-stage HER2+ breast cancer, and in combination with capecitab...

February 18, 2025 | News

Stryker Unveils ProCeed Hospital Bed to Enhance Patient Care and Ease Caregiver Burden

Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of the ProCeed hospital bed, offering simplicity while enhancing care acr...

February 17, 2025 | News

Restore Vision Doses First Patient in World’s First Optogenetic Gene Therapy Trial for Retinitis Pigmentosa

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial. R...

February 14, 2025 | News

Sequential Skin and AMILI Secure UK-Singapore Grant to Advance Gut-Skin Microbiome Research

Sequential Skin Ltd, a world leader in skin microbiome testing, and AMILI, a leading expert in gut microbiome science, are proud to announce that they have...

February 13, 2025 | News

Cubresa Partners with Siemens Healthineers to Advance BrainPET™ Integration in MRI Scanners

Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract d...

February 12, 2025 | News

Fresenius Kabi Launches Calcitonin Salmon Injection to Treat Bone Disorders and Hypercalcemia

Fresenius Kabi, an operating company of Fresenius, announced it has introduced Calcitonin Salmon Injection, USP Synthetic, a calcium regulator, for the tre...

February 11, 2025 | News

Thermo Fisher Secures FDA Clearance for Multiplex Test Targeting Four Major Respiratory Viruses

Thermo Fisher Scientific has announced the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Applied Biosystems™ TaqPath&trad...

February 10, 2025 | News

Gene Solutions Introduces AI-Powered Blood Test to Transform Lung Cancer Screening in Asia

Asia is the region most impacted by lung cancer, accounting for 63.1% of newly diagnosed lung cancers and 62.9% of lung cancer deaths worldwide(1). M...

February 06, 2025 | News

Henlius Secures EU Approval for Serplulimab Expanding Global Cancer Care

Shanghai Henlius Biotech, Inc. (2696.HK) has secured a significant milestone with the European Commission (EC) approval of HANSIZHUANG (serplulimab...

February 06, 2025 | News

Stay Connected